NJ Accutane Litigation Trimmed By 160 Suits

A New Jersey state judge on Wednesday dismissed 160 out of the thousands of consolidated cases claiming that Hoffmann-La Roche Ltd.'s acne drug Accutane caused inflammatory bowel disease, ruling based on...

Already a subscriber? Click here to view full article